Alexion Pharmaceuticals
(ETR) AXP
Alexion Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$6.26B
Net Income (TTM)
$681.80M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
AXP News
AXP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alexion Pharmaceuticals
AXP Financials
Key Financial Metrics (TTM)
Gross Margin
91%
Operating Margin
47%
Net Income Margin
10%
Return on Equity
5%
Return on Capital
17%
Return on Assets
3%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$5.52B
Operating Income
$2.86B
EBITDA
$1.00B
Operating Cash Flow
$3.00B
Capital Expenditure
$106.70M
Free Cash Flow
$2.90B
Cash & ST Invst.
$3.00B
Total Debt
$2.56B
Alexion Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$1.64B
+13.3%
Gross Profit
$1.51B
+13.4%
Gross Margin
92.34%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
3,837
N/A
Net Income
$636.00M
+14.1%
EBITDA
$705.30M
-9.4%
Quarterly Fundamentals
Net Cash
$937.30M
+974.3%
Accounts Receivable
$1.47B
+9.5%
Inventory
$803.90M
+37.0%
Long Term Debt
$2.39B
+1.9%
Short Term Debt
$143.20M
+13.0%
Return on Assets
3.33%
N/A
Return on Invested Capital
17.36%
N/A
Free Cash Flow
$507.40M
-5.6%
Operating Cash Flow
$637.60M
+16.0%